The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on General Meeting

15 Jun 2021 16:27

RNS Number : 9969B
Iconic Labs PLC
15 June 2021
 

For immediate release

 

Update on Administration and adjournment of General Meeting

 

The Joint Administrators provide the following update on progress since their appointment:

 

Update

1. The Joint Administrators have not made material progress in assessing the financial position of the Company as they await a Statement of Affairs which is required to be provided by the directors together with various accounting and financial records of the Company which have also been requested from the directors.

2. The Joint Administrators have, however, obtained access to a bank account of the Company which currently has a negative cash balance. The Joint Administrators are trying to establish whether the Company has any other bank accounts.

3. The Joint Administrators are not aware of any employees employed within the Company or any business activity being conducted by the Company, and therefore there appears to be no urgent operating cash pressure on the Company save for the costs being incurred in the administration.

4. The Joint Administrators have received unsolicited notices of claim from multiple unsecured creditors.

5. The Joint Administrators have received notice from the secured creditor of the Company suggesting that the obligations secured by its debenture extend beyond the debt originally claimed by it and cover a wider range of potential claims, including under the secured creditor's investment agreement with the Company. The secured creditor has further notified the Joint Administrators of several breaches of that investment agreement and that it is in the process of calculating the damages it claims are due as a result. The Joint Administrators consider that, should these claims prove to be correct, the sums due to the secured creditor are likely considerably to exceed the amount of the debt originally claimed by it.

6. The Joint Administrators act for the general body of creditors of the Company. They intend to instruct independent legal advisers to advise them on the merits of the various claims that have been asserted to date, including by the directors against a range of third parties. Upon receipt of that advice, the Joint Administrators will then consider whether such claims should be pursued for the benefit of the Company, its creditors and, potentially, its shareholders. Even if sufficient asset recoveries were to be made by the Joint Administrators towards discharging the claims of the secured creditor which are agreed in full, the Company would still remain in administration unless and until sufficient further recoveries can be made which would enable the Joint Administrators to pay all unsecured and other creditors and the costs of the administration in full. The Joint Administrators hope to be in a position to publish a summary of the legal advice being sought by them once received.

General Meeting

7. The Joint Administrators received representations from European High Growth Opportunities Fund ("EHGO") urging the Joint Administrators to proceed with the General Meeting originally scheduled for 2.00pm today, 15 June 2021. The Joint Administrators have agreed with EHGO that the General Meeting would be, and accordingly it has been, adjourned until 2.00pm on 29 June 2021 to enable the Joint Administrators to continue their investigations into the Company's affairs in the meantime and to update shareholders as necessary. The Joint Administrators hope to explore discussions with EHGO in relation to meaningful and achievable financing proposals to benefit the Company's creditors and, potentially, shareholders.

8. The Joint Administrators will provide further updates in due course.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFAMATMTBBBRB
Date   Source Headline
1st May 20187:02 amRNSAnnual Accounts and Fundraising Update
26th Mar 20187:00 amRNSLandmark deal to launch CellPlan insurance in Asia
19th Mar 20187:00 amRNSGranted Innovate UK KTP for Stem Cell Research
27th Feb 20187:00 amRNSLicence Award from the Human Tissue Authority
19th Feb 20187:00 amRNSBoard Changes and Launch of Wideacademy Platform
21st Dec 20177:00 amRNSCorporate Update
2nd Nov 20177:00 amRNSRevenue generation with White Apex agreement
12th Oct 20177:00 amRNSCellPlan expansion, e-commerce platform launch UK
11th Oct 20177:00 amRNSPartner Secured to Expand into MENA & Asia-Pacific
29th Sep 20177:00 amRNSInterim Results
25th Sep 20177:00 amRNSWideacademy Update, Presenting at Investor Event
15th Aug 20177:00 amRNSRaises £750,000 to support Company's divisions
31st Jul 20177:00 amRNSResearch Licence Granted from HTA
24th Jul 20177:00 amRNSNew product to target the dental market
21st Jul 20177:00 amRNSCellPlan launches E-Commerce Platform in the UK
12th Jul 20177:00 amRNSCorporate Charity Commitment
4th Jul 20177:00 amRNSAgreement to Roll Out CellPlan in Brazil
3rd Jul 20177:00 amRNSInvestor Evening and CFO Now Employed Full-time
27th Jun 20177:00 amRNSRevenue with launch of CellPlan
22nd Jun 20173:30 pmRNSResults of AGM
22nd Jun 20177:00 amRNSAGM Statement and Notice of Investor Evening
12th Jun 20177:00 amRNSWideAcademy Strategic Update
6th Jun 20177:00 amRNSLaunch of CellPlan set to generate maiden revenues
2nd Jun 20177:00 amRNSWideCells Named 21st in Global DISRUPT 100 List
23rd May 20177:00 amRNSAttendance at British Dental Conference
15th May 20177:00 amRNSAttendance at Brazilian Conference
4th May 20172:15 pmRNSHolding(s) in Company
2nd May 20177:40 amRNSPosting of Report and Accounts and Notice of AGM
12th Apr 20171:00 pmRNSPlacing
30th Mar 20177:00 amRNSPreliminary Results
16th Feb 20177:00 amRNSBoard Appointment
31st Jan 20177:00 amRNSDirector Purchases and Grant of Options
30th Jan 20174:40 pmRNSSecond Price Monitoring Extn
30th Jan 20174:35 pmRNSPrice Monitoring Extension
26th Jan 201710:30 amRNSGrant of Options
24th Jan 20177:00 amRNSExtends CellPlan Roll Out & New Product Launch
9th Jan 20177:00 amRNSDefinitive Agreement with BioVault for CellPlan
30th Nov 20167:00 amRNSNew Revenue Stream: Stem Cell Research, Manchester
7th Nov 20167:00 amRNSLOI with 1st Cord Blood Bank to Roll Out CellPlan
24th Oct 20167:00 amRNSCorporate Update
10th Oct 20167:00 amRNSUpdate on CellPlan
27th Sep 20167:00 amRNSPartners with University of Westminster
5th Sep 20167:00 amRNSLaunches WideCells Brasil
12th Aug 20167:00 amRNSHoldings In Company
5th Aug 20167:00 amRNSUpdate on Manchester Facility and Appointments
27th Jul 20168:00 amRNSPlacing & First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.